Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 23 Oct, 15:12 UTC

Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinations that could be used to treat MSS CRC. The post Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to…